Corporations aren't looking just for app developers. Johnson & Johnson and GlaxoSmithKline each put $50 million last year into a $200 million venture fund to support early-stage biotech firms. In addition, J&J is creating four innovation centers--in Boston, London, Shanghai, and San Francisco--to fund early-stage life-science research and help push products forward faster. Roughly 70 J&J scientists and research and development executives at the centers will mentor entrepreneurs and provide industry introductions. The company also created a biotech incubator at its Janssen Labs in San Diego, where early-stage companies can rent office and lab space without having to commit any of their research to J&J.